The OCTRI Education Program is accepting letters of intent for the KL2 mentored career development award funded by NIH/NCATS. Faculty at OHSU, Portland State University, University of Oregon, and Oregon State University are eligible to apply.

The deadline for letter of intent submission is now passed.

This opportunity supports the research training and career development of clinical and translational researchers for a maximum of two years. All research proposed for this program must involve either clinical or translational research defined as involving human subjects or populations, or research that has direct application to human health. The scholar is expected to apply for an independent career development award such as a K01, K07, K08, K22, K23, K25 or VA CDA, or an independent grant such as a R01 or equivalent.

• $25,000 per year in research and travel funds.
  
• Tuition-waiver costs for participation in the Human Investigations Program, including the Master of Clinical Research or Certificate in Human Investigation tracks. Courses or conferences outside of this program should be paid from research and travel funds.
  
• Participation in OCTRI-supported networking and mentoring activities such as offered by the OCTRI Scholars Program.
• Participation in a monthly Clinical and Translational Science Journal Club. The primary objective is understanding research literature with a focus on disease-oriented, translational research topics. The secondary objective is team building through periodic group presentations.
  
• Priority support from OCTRI cores and services through small grant support. View open opportunities.
  
  

Eligibility

Applicants must meet all the following requirements for the OCTRI KL2 award:

• U.S. Citizen or Permanent Resident. Individuals with temporary or student visas are not eligible
• Hold a clinical doctorate (e.g. MD/DO, DMD/DDS, DNS, PharmD, ND, OD, DC) or a research doctorate (PhD) and have a current or pending primary faculty appointment at OHSU, PSU, OSU or UO as an Assistant Professor level or equivalent. Clinicians must have completed specialty or subspecialty training by the time of the award.
• No prior funding as principal investigator on an NIH research grant, including an R01 or any K series grant; or PI of a subproject of a program project grant (P01), center grant (P50, P60, U54); or other equivalent grant awards. Candidates are eligible if they have been supported by an NRSA grant (F or T) or an NIH small grant (R03 or R21).
• KL2 applicants may not simultaneously submit or have pending an application for any other PHS mentored career development award (e.g. K07, K08, K22, or K23) that duplicates the provisions of the KL2 program.

Selection Criteria  

A KL2 selection committee will follow the model of the NIH peer review process for K awards. Selection criteria will focus on the strengths and potential of the candidate to become a leading multidisciplinary investigator judged in five major domains:

• Potential of the Applicant: potential to conduct multidisciplinary research judging by research expertise and prior training; publications; prior participation in research.
• Research Plan: Scientific value, potential clinical importance, and feasibility of the written multidisciplinary research plan
• Training Plan: Quality, appropriateness, and composition of the multidisciplinary team of the proposed mentors; plan to gain didactic and other training.
• Mentors: Tangible commitment and resources provided by the home department, including protected research time, and suitability of the available clinical and laboratory infrastructure and multidisciplinary team

• Career Potential: Global assessment of the likelihood that the candidate will develop a career as an outstanding independent investigator and conduct research that will have an important impact on health. Individuals from underrepresented groups in research (women, ethnic minorities, and the disabled) are encouraged to apply. Special consideration will be given to individuals in disciplines traditionally under-represented in clinical and translational research.
  
  

Key Dates 2019: